KreaMedica Inc.

Meet with KreaMedica (Vik Pham) at the LSX World Congress #LSXWorld event happening in Boston, MA on September 11-12, 2024. We are partnering with #biotech and #consultants to advance drug assets into transformative therapies. #LSX2024 #LSXWorldCongress #pharmapartners #drugdevelopment #preclinical #toxconsultants

The United States is one of the largest and most influential markets for pharmaceuticals, making it an important destination for many global clinical development programs. Understanding how to successfully transition a clinical program to the U.S. is crucial to advance your product toward the market, and requires a thorough understanding of FDA regulations, documentation requirements and strategic considerations. Read on to explore what it takes to navigate these challenges and how KreaMedica can help you successfully conduct clinical trials in one of the world’s most important markets. https://bit.ly/4fGxLl0   #preclinicaldevelopment #nonclinicaldevelopment #drugdevelopment #biotech #toxconsultants #toxicologyconsultants #preIND #FDA #USFDA #preINDmeeting #INDconsultation #pind

KreaMedica is #hiring. Know anyone who might be interested?

We are looking for a Scientific Program Director to join KreaMedica! If you are looking for an exciting opportunity within a great team, we encourage you to submit your application to mjlachapelle@kreamedica.com Please reference job posting: #PM2024

Obtaining FDA approval for your drug requires a blend of scientific rigor, regulatory competence, and strategic planning. Early collaboration with the FDA is essential to your success. This article covers several aspects of conducting a successful pre-IND meeting with FDA. Read on to learn the how KreaMedica can help you get there. https://bit.ly/4bLbSxP #preclinicaldevelopment #nonclinicaldevelopment #drugdevelopment #biotech #toxconsultants #toxicologyconsultants #preIND #FDA #USFDA #preINDmeeting #INDconsultation #pind

In recent years, the resurgence of interest in psychedelic substances as potential therapeutic tools has captured both scientific curiosity and public imagination. However, the journey towards integrating these substances into mainstream medicine is fraught with challenges. From regulatory hurdles, laws, and regulations to societal stigmas, the path to developing psychedelic treatments is riddled with complexities. Read on as KreaMedica explores some of the common hurdles to developing psychedelic treatments as well as the research being done to bring these treatments into mainstream use and widespread: https://bit.ly/3Kj3v12 #preclinicaldevelopment #nonclinicaldevelopment #drugdevelopment #toxicology #biotech #toxconsultants #toxicologyconsultants #psychedelics

Meet with Karl-Rudolf Erlemann (Rudi) and Vik Pham at the San Diego Bio International Convention event happening from June 3 to 6th. We are partnering with #biotech and #consultants to advance drug assets into transformative therapies. #BIO2024 #BioInternational2024 #partneringONE #BIOEvents #pharmapartners #drugdevelopment #preclinical #toxconsultants

Is there a better way to start your day in San Diego? Let's meet in front of the Hard Rock Hotel San Diego and go to the harbourfront in good company. I guess we will enjoy more the June-Gloom and not a sunrise... but with friends and peers.

🔊 (sound on) Yesterday in Montreal, BIOTECanada brought together its members in Quebec, invited guests, and key stakeholders to Espace CDPQ for a lively panel discussion on enhancing Canada’s regulatory competitiveness and the attraction of investment into the biotechnology sector in Canada. Highlights included: * The pivotal role and intrinsic value of anchor companies within the expansive biotech ecosystem * Strategies for Canada to secure and retain biotech companies * Insights into the venture capital landscape and the broader investment climate * How organizations such as the Fonds de solidarité FTQ, as institutional investors, navigate the biotech innovation space, focusing on capital availability, investment opportunities, returns and the mandate on behalf of Quebecers * The crucial role of leveraging talent and mentorship opportunities to drive significant economic impact. A heartfelt thank you to our esteemed panelists: Mounia Azzi, PhD, Geneviève Guertin, Michael Mee, our host, Amplitude Ventures and to everyone who attended the event, your engagement fuels our collective path toward continued success in the biotech ecosystem. What was your most notable take-away from the event? If you missed the event, stay tuned for more opportunities to connect with us! Let’s keep the momentum going! #biotech #Canada #investment #innovation #policy #ecosystem #lifesciences #quebec adMare BioInnovations, J.P. Morgan, Ventus Therapeutics, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Canadian Advanced Therapies Training Institute, KreaMedica Inc., Mintz, Epitopea, BIOQuebec, Domain Therapeutics, EVAH - Evolution for Animal Health, Health Innovation Capital, Molecular Forecaster, Merck, Thérapeutiques Thryv

Innovative approaches in developing T-cell-engaging molecules are shifting the idea of what’s possible in our medical landscape. To see these transformative immunotherapies change lives, developers must create, implement, and execute the right strategies to get these products to market, beginning with a non-clinical development strategy. Read on as we outline the best approach to tackle your strategy. https://bit.ly/3wtlLBG #tcells #preclinicaldevelopment #nonclinicaldevelopment #drugdevelopment #toxicology #biotech #startup #toxconsultants #toxicologyconsultants